A previous report indicated that SARS-CoV-2-reactive CD8+ T cells from convalescent patients with mild COVID-19 were predominantly TEMRA cells expressing CD28, suggesting a protective role (Neidleman et al., 2020). The gene discussed is CD28; the disease is COVID-19.